Research and Development

Roche has unveiled new data on the efficacy of Tecentriq (atezolizumab) in combination with chemotherapy (carboplatin and etoposide) for the …

The sun is out in the UK, it’s Friday, and the July/August issue of Pharmafocus is going to print. And, …

A new report from Cancer Research UK has indicated that the number of UK  citizens over the age of 75 …

Anika Therapeutics has become the latest in a recent string of firms to suffer a failure in a late-stage trial, …

Novo Nordisk has released new data for its oral semaglutide diabetes therapy from two trials, showing that the GLP-1 analogue …

Aquinnah Pharmaceuticals has announced that it has been awarded a $3.4 million grant from the National Institute of Neurological Disorders …

Research commissioned by Innovate UK and the British In Vitro Diagnostics Association (BIVDA) has revealed that the NHS could save …

This week, shares in Sarepta Therapeutics rocketed by 80% after the company released preliminary data from a Phase 1/2a trial …

Kallyope and Novo Nordisk have entered into a research collaboration and option agreement to discover novel peptide therapeutics for the …

A blood test designed to support the clinical determination of whether a child is on the autistic spectrum has been …

Despite its highly-publicised transgressions recently, tech giant Facebook is looking to do the right thing by wading into the ongoing …

CAR-T is emerging as one of the most potentially exciting therapies in the industry, particularly as a beacon for the …

Biogen currently has the only product on the market approved to treat spinal muscular atrophy (SMA), in Spinraza, and that …

From breach scandals to GDPR, data is becoming a more prominent part of our everyday lives. This holds great potential …

With the advent of another week, there’s another trial discontinuation in the industry as Teva announces its decision to terminate …